Risk and outcomes of frailty in Alzheimer's dementia
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how frailty affects people newly diagnosed with Alzheimer's dementia. It aims to understand risk factors and outcomes to help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Alzheimer's dementia within the past 3 months
- You are 65 years or older
- You live at home (not in a nursing home or assisted living)
- You can walk 5 meters (about 16 feet) with or without a cane or walker
- You have a family member or friend who can help with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people with Parkinson's disease become physically frail. It aims to find factors that may help predict or prevent frailty.
This study follows older adults without dementia to see how frailty and memory changes happen over time. It helps doctors understand how to better support healthy aging.
This trial aims to improve how frailty is detected in older adults. It tests a new approach to identify frailty early, which could help prevent health problems.
This trial looks at whether “frailty” (how weak or vulnerable someone is) changes short- and long-term outcomes after surgery. It may help doctors better predict who could benefit from extra support before and after surgery.
This study looks at whether frailty (how weak or vulnerable someone is) changes the risk of heart-related events and death in people with COPD. It may help doctors better predict who is at higher risk and tailor care.
This study looks at how a personalized “frailty” checklist can help older adults (65+) understand their health and make better choices. You may be asked to complete questionnaires and a frailty-type assessment to see if the approach works for you.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.